An Observational Study of Avastin and Conventional Chemotherapy in Patients >/= 70 Years of Age With Previously Untreated Metastatic Colorectal Cancer (AVAPLUS)
NCT ID: NCT01676922
Last Updated: 2016-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
256 participants
OBSERVATIONAL
2011-08-31
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Previously untreated metastatic colorectal cancer
* Patient considered suitable to receive chemotherapy with or without Avastin
Exclusion Criteria
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aalst, , Belgium
Antwerp, , Belgium
Assebroek, , Belgium
Bonheiden, , Belgium
Bornem, , Belgium
Brasschaat, , Belgium
Bruges, , Belgium
Brussels, , Belgium
Brussels, , Belgium
Brussels, , Belgium
Ghent, , Belgium
Haine-Saint-Paul, , Belgium
Hasselt, , Belgium
Hornu, , Belgium
Ieper, , Belgium
Kortrijk, , Belgium
Leuven, , Belgium
Lier, , Belgium
Liège, , Belgium
Mechelen, , Belgium
Mons, , Belgium
Mont-godinne, , Belgium
Namur, , Belgium
Ostend, , Belgium
Oudenaarde, , Belgium
Roeselare, , Belgium
Ronse, , Belgium
Seraing, , Belgium
Sint-Niklaas, , Belgium
Tongeren, , Belgium
Turnhout, , Belgium
Verviers, , Belgium
Wilrijk, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML27768
Identifier Type: -
Identifier Source: org_study_id